Norway Savings Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Norway Savings Bank’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-265	Closed	-$7.44K	–	143
2022 Q4	$7.44K	Hold	265	–	–	﹤0.01%	248
2022 Q3	$7K	Hold	265	–	–	﹤0.01%	253
2022 Q2	$6K	Hold	265	–	–	﹤0.01%	262
2022 Q1	$8K	Hold	265	–	–	﹤0.01%	261
2021 Q4	$9K	Hold	265	–	–	﹤0.01%	262
2021 Q3	$12K	Hold	265	–	–	0.01%	261
2021 Q2	$15K	Hold	265	–	–	0.01%	259
2021 Q1	$14K	Hold	265	–	–	0.01%	260
2020 Q4	$11K	Hold	265	–	–	0.01%	275
2020 Q3	$9K	Hold	265	–	–	0.01%	262
2020 Q2	$14K	Hold	265	–	–	0.01%	214
2020 Q1	$9K	Hold	265	–	–	0.01%	219
2019 Q4	$13K	Hold	265	–	–	0.01%	220
2019 Q3	$9K	Hold	265	–	–	0.01%	215
2019 Q2	$13K	Hold	265	–	–	0.01%	205
2019 Q1	$18K	Hold	265	–	–	0.02%	195
2018 Q4	$12K	Buy	+265	New	+$16.4K	0.01%	207

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Norway Savings Bank's AGIO Position: Q1 2023 in Review

Norway Savings Bank sold out of Agios Pharmaceuticals (AGIO) in Q1 2023, closing a stake of 265 shares — an estimated $7.44K sold.

Norway Savings Bank first reported a position in AGIO in Q4 2018 and held it in 17 quarters. The position peaked at $18K in Q1 2019. 163 funds tracked by Wall St. Rank hold AGIO as of Q1 2023.

Norway Savings Bank reported no remaining Agios Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Norway Savings Bank sold 265 Agios Pharmaceuticals shares in Q1 2023, an estimated $7.44K.
Norway Savings Bank first reported a position in Agios Pharmaceuticals in Q4 2018 and held it in 17 quarters.
Norway Savings Bank's Agios Pharmaceuticals position peaked at $18K in Q1 2019.
163 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2023.

Based on Norway Savings Bank's 13F filing for Q1 2023, filed 11 Apr 2023.